Hologic, Inc. (0J5Q.L)
USD 57.45
(1.41%)
USD 57.45
(1.41%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 789.5 Million USD | 73.14% |
| 2023 | 456 Million USD | -64.98% |
| 2022 | 1.3 Billion USD | -30.43% |
| 2021 | 1.87 Billion USD | 67.82% |
| 2020 | 1.11 Billion USD | 647.74% |
| 2019 | -203.6 Million USD | -82.93% |
| 2018 | -111.3 Million USD | -114.73% |
| 2017 | 755.5 Million USD | 128.39% |
| 2016 | 330.8 Million USD | 151.37% |
| 2015 | 131.6 Million USD | 660.69% |
| 2014 | 17.3 Million USD | 101.48% |
| 2013 | -1.17 Billion USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 246.5 Million USD | 172.08% |
| 2024 Q2 | 169.9 Million USD | -31.08% |
| 2024 Q3 | 194.5 Million USD | 14.48% |
| 2024 Q4 | 178.6 Million USD | -8.17% |
| 2023 FY | 456 Million USD | -64.98% |
| 2023 Q2 | 218.5 Million USD | 16.6% |
| 2023 Q1 | 187.4 Million USD | 57.88% |
| 2023 Q4 | 90.6 Million USD | 323.7% |
| 2023 Q3 | -40.5 Million USD | -118.54% |
| 2022 Q1 | 499.2 Million USD | 51.82% |
| 2022 FY | 1.3 Billion USD | -30.43% |
| 2022 Q4 | 118.7 Million USD | -48.03% |
| 2022 Q3 | 228.4 Million USD | -49.88% |
| 2022 Q2 | 455.7 Million USD | -8.71% |
| 2021 FY | 1.87 Billion USD | 67.82% |
| 2021 Q3 | 268.39 Million USD | -56.7% |
| 2021 Q4 | 328.8 Million USD | 22.5% |
| 2021 Q1 | 654.4 Million USD | 32.23% |
| 2021 Q2 | 619.9 Million USD | -5.27% |
| 2020 Q3 | 137.9 Million USD | 43.2% |
| 2020 Q4 | 494.9 Million USD | 258.88% |
| 2020 FY | 1.11 Billion USD | 647.74% |
| 2020 Q1 | 386.1 Million USD | 412.63% |
| 2020 Q2 | 96.3 Million USD | -75.06% |
| 2019 FY | -203.6 Million USD | -82.93% |
| 2019 Q4 | -123.5 Million USD | -231.52% |
| 2019 Q3 | 93.9 Million USD | 134.45% |
| 2019 Q1 | 98.6 Million USD | 95.25% |
| 2019 Q2 | -272.6 Million USD | -376.47% |
| 2018 Q2 | -681.4 Million USD | -267.54% |
| 2018 Q3 | 112.9 Million USD | 116.57% |
| 2018 Q4 | 50.5 Million USD | -55.27% |
| 2018 FY | -111.3 Million USD | -114.73% |
| 2018 Q1 | 406.7 Million USD | 391.78% |
| 2017 Q2 | 526.79 Million USD | 509.02% |
| 2017 FY | 755.5 Million USD | 128.39% |
| 2017 Q3 | 59.5 Million USD | -88.71% |
| 2017 Q1 | 86.5 Million USD | -6.08% |
| 2017 Q4 | 82.7 Million USD | 38.99% |
| 2016 Q4 | 92.1 Million USD | 8.61% |
| 2016 Q1 | 84.9 Million USD | 238.25% |
| 2016 Q2 | 68.9 Million USD | -18.85% |
| 2016 Q3 | 84.8 Million USD | 23.08% |
| 2016 FY | 330.8 Million USD | 151.37% |
| 2015 Q4 | 25.1 Million USD | -14.63% |
| 2015 FY | 131.6 Million USD | 660.69% |
| 2015 Q2 | 47.8 Million USD | 63.7% |
| 2015 Q1 | 29.2 Million USD | 3.91% |
| 2015 Q3 | 29.4 Million USD | -38.49% |
| 2014 Q1 | -5.3 Million USD | 99.52% |
| 2014 FY | 17.3 Million USD | 101.48% |
| 2014 Q3 | 11.3 Million USD | 167.26% |
| 2014 Q2 | -16.8 Million USD | -216.98% |
| 2014 Q4 | 28.1 Million USD | 148.67% |
| 2013 Q1 | 3.11 Million USD | 0.0% |
| 2013 Q4 | -1.11 Billion USD | -10026.36% |
| 2013 Q3 | -11 Million USD | 78.48% |
| 2013 Q2 | -51.1 Million USD | -1739.0% |
| 2013 FY | -1.17 Billion USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 676.762% |
| Accuray Incorporated | -15.54 Million USD | 5178.803% |
| Align Technology, Inc. | 445.05 Million USD | -77.395% |
| Elevance Health Inc. | 5.98 Billion USD | 86.813% |
| AxoGen, Inc. | -21.71 Million USD | 3735.568% |
| Boston Scientific Corporation | 1.59 Billion USD | 50.439% |
| CVS Health Corporation | 8.34 Billion USD | 90.538% |
| Cardinal Health, Inc. | 852 Million USD | 7.336% |
| Centene Corporation | 2.7 Billion USD | 70.781% |
| DaVita Inc. | 691.53 Million USD | -14.166% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 84.939% |
| Humana Inc. | 2.48 Billion USD | 68.28% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 6.573% |
| Laboratory Corporation of America Holdings | 418 Million USD | -88.876% |
| Masimo Corporation | 81.5 Million USD | -868.712% |
| McKesson Corporation | 3 Billion USD | 73.701% |
| Patterson Companies, Inc. | 185.93 Million USD | -324.62% |
| Quest Diagnostics Incorporated | 854 Million USD | 7.553% |
| ResMed Inc. | 1.02 Billion USD | 22.67% |
| Henry Schein, Inc. | 416 Million USD | -89.784% |
| Teladoc Health, Inc. | -220.36 Million USD | 458.264% |
| Universal Health Services, Inc. | 717.79 Million USD | -9.99% |
| Veeva Systems Inc. | 525.7 Million USD | -50.179% |
| Baxter International Inc. | 2.65 Billion USD | 70.275% |
| Becton, Dickinson and Company | 1.48 Billion USD | 46.799% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 56.09% |
| Danaher Corporation | 4.2 Billion USD | 81.202% |
| Stryker Corporation | 3.16 Billion USD | 75.055% |
| Medtronic plc | 3.67 Billion USD | 78.523% |